Newsletter

141080 - LigaChem Biosciences Inc.

141080 Summary
Biopharma
Stock Price & Overview
₩92,000 +3,700 (+4.19%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩92,000  ≈ US$66  ·  Market cap ₩3.4tn (≈ $2.4bn)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

141080 DART Filings

DART

Large business group status disclosure — quarterly, individual company

Filing08/31/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Supplier Payment Terms and Dispute-Resolution Disclosure

Governance08/14/26title translated
DART

Material matter: sole development and out-licensing rights secured for LNCB74, a B7H4-ADC

Filing08/07/26title translated
DART

Securities issuance result (voluntary)

Filing07/24/26title translated
DART

Material event report (paid-in capital increase)

Filing07/22/26title translated
DART

Material event report (convertible bond issuance)

Filing07/22/26title translated
DART

Material event report (paid-in capital increase)

Filing07/16/26title translated
DART

Material event report (convertible bond issuance)

Filing07/16/26title translated
DART

Material matter: milestone royalty received on LCB97

Filing07/09/26title translated
DART

Material event report (paid-in capital increase)

Filing06/26/26title translated
DART

Material event report (convertible bond issuance)

Filing06/26/26title translated
DART

Large business group status disclosure — annual and Q1, individual company

Filing06/01/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
DART

Material matter: US IND cleared for the phase 1/2 trial of LCB02A, a CLDN18.2 antibody-drug conjugate

Filing05/14/26title translated
7 routine filings (insider holdings reports, IR schedules)DART

5% Ownership Report — Large Holdings ×2

Ownership08/04/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership08/04/26title translated
DART

5% Ownership Report — Short Form

Ownership07/31/26title translated
DART

Insider / Major Shareholder Holdings Report

Ownership07/24/26title translated
DART

5% Ownership Report — Large Holdings

Ownership07/24/26title translated
DART

Investor Relations Event

IR06/30/26title translated
DART

Investor Relations Event ×2

IR05/14/26title translated
22 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 141080

SymbolLast Price
028300HLB Co., Ltd.₩33,750
+2.9%
298380ABL Bio Inc.₩71,400
+5.6%
000250Samchundang Pharm₩157,000
+1.0%
087010Peptron, Inc.₩157,300
+7.3%
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
347850D & D Pharmatech, Inc.₩49,200
+1.4%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.